APO RESEARCH · REPORT
Soliris
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Product & engineering
Understand the product.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Selected research
Industry Growth & Trends
Global Soliris Industry Growth and Trends Forecast to 2032
Market perspective
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
Prior to COVID-19, the China market for Soliris was anticipated to grow from US$ 43.15 million in 2020 to US$ 105.67 million by 2026; it is expected to grow at a CAGR of 14.86% during 2021–2026, whereas post-COVID-19 scenario, the market for Soliris is projected to grow from US$ 40.9 million in 2020 (a change by ~-6.4% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 100.58 million by 2026; it is expected to grow at a CAGR of 14.75% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Soliris market.The classification of Soliris includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2019 is about 76.36%, and the proportion is in increasing trend from 2013 to 2018.
Soliris is widely used for patients of PNH, aHUS and other. The most proportion of Soliris is used for patients of PNH, and the proportion in 2019 is 66.85%.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Soliris market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Soliris market size, estimates, and forecasts are presented in terms of sales volume (Unit) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Soliris market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Soliris.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Soliris market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Soliris Market by Company
Alexion
Soliris Segment by Type
Plasma Exchange
Plasma Infusion
Soliris Segment by Application
PNH
aHUS
Other
Soliris Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soliris market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Soliris and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soliris.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soliris manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Soliris in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasma Exchange
- Plasma Infusion
Applications
- PNH
- aHUS
- Other
Companies covered
- Alexion
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Soliris Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Soliris Sales Estimates and Forecasts (2021-2032)
- 1.3 Soliris Market by Type
- 1.3.1 Plasma Exchange
- 1.3.2 Plasma Infusion
- 1.4 Global Soliris Market Size by Type
- 1.4.1 Global Soliris Market Size Overview by Type (2021-2032)
- 1.4.2 Global Soliris Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Soliris Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Soliris Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Soliris Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Soliris Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Soliris Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Soliris Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Soliris Industry Trends
- 2.2 Soliris Industry Drivers
- 2.3 Soliris Industry Opportunities and Challenges
- 2.4 Soliris Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Soliris Revenue (2021-2026)
- 3.2 Global Top Players by Soliris Sales (2021-2026)
- 3.3 Global Top Players by Soliris Price (2021-2026)
- 3.4 Global Soliris Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Soliris Major Company Production Sites & Headquarters
- 3.6 Global Soliris Company, Product Type & Application
- 3.7 Global Soliris Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Soliris Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Soliris Players Market Share by Revenue in 2025
- 3.8.3 2025 Soliris Tier 1, Tier 2, and Tier 3
4 Soliris Regional Status and Outlook
- 4.1 Global Soliris Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Soliris Historic Market Size by Region
- 4.2.1 Global Soliris Sales in Volume by Region (2021-2026)
- 4.2.2 Global Soliris Sales in Value by Region (2021-2026)
- 4.2.3 Global Soliris Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Soliris Forecasted Market Size by Region
- 4.3.1 Global Soliris Sales in Volume by Region (2027-2032)
- 4.3.2 Global Soliris Sales in Value by Region (2027-2032)
- 4.3.3 Global Soliris Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Soliris by Application
- 5.1 Soliris Market by Application
- 5.1.1 PNH
- 5.1.2 aHUS
- 5.1.3 Other
- 5.2 Global Soliris Market Size by Application
- 5.2.1 Global Soliris Market Size Overview by Application (2021-2032)
- 5.2.2 Global Soliris Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Soliris Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Soliris Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Soliris Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Soliris Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Soliris Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Soliris Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Alexion
- 6.1.1 Alexion Company Information
- 6.1.2 Alexion Business Overview
- 6.1.3 Alexion Soliris Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Alexion Soliris Product Portfolio
- 6.1.5 Alexion Recent Developments
7 North America by Country
- 7.1 North America Soliris Sales by Country
- 7.1.1 North America Soliris Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Soliris Sales by Country (2021-2026)
- 7.1.3 North America Soliris Sales Forecast by Country (2027-2032)
- 7.2 North America Soliris Market Size by Country
- 7.2.1 North America Soliris Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Soliris Market Size by Country (2021-2026)
- 7.2.3 North America Soliris Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Soliris Sales by Country
- 8.1.1 Europe Soliris Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Soliris Sales by Country (2021-2026)
- 8.1.3 Europe Soliris Sales Forecast by Country (2027-2032)
- 8.2 Europe Soliris Market Size by Country
- 8.2.1 Europe Soliris Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Soliris Market Size by Country (2021-2026)
- 8.2.3 Europe Soliris Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Soliris Sales by Country
- 9.1.1 Asia-Pacific Soliris Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Soliris Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Soliris Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Soliris Market Size by Country
- 9.2.1 Asia-Pacific Soliris Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Soliris Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Soliris Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Soliris Sales by Country
- 10.1.1 South America Soliris Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Soliris Sales by Country (2021-2026)
- 10.1.3 South America Soliris Sales Forecast by Country (2027-2032)
- 10.2 South America Soliris Market Size by Country
- 10.2.1 South America Soliris Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Soliris Market Size by Country (2021-2026)
- 10.2.3 South America Soliris Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Soliris Sales by Country
- 11.1.1 Middle East and Africa Soliris Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Soliris Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Soliris Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Soliris Market Size by Country
- 11.2.1 Middle East and Africa Soliris Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Soliris Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Soliris Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Soliris Value Chain Analysis
- 12.1.1 Soliris Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Soliris Production Mode & Process
- 12.2 Soliris Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Soliris Distributors
- 12.2.3 Soliris Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst